COSMOS Pharmaceutical Corporation (3349) Stock Statistics & Valuation Metrics

COSMOS Pharmaceutical Corporation has a market cap or net worth of ¥647.78B. The enterprise value is ¥571.86B.

COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

COSMOS Pharmaceutical Corporation’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of COSMOS Pharmaceutical Corporation is ―. COSMOS Pharmaceutical Corporation’s PEG ratio is ―.

In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of 964.99B and earned 24.45B in profits. Earnings per share was 308.61.

In the last 12 months, operating cash flow was 18.82B and capital expenditures 0.00, giving a free cash flow of 18.82B billion.

COSMOS Pharmaceutical Corporation pays an annual dividend of ¥32.5, resulting in a dividend yield of 0.72%

COSMOS Pharmaceutical Corporation upcoming earnings date is Jul 11, 2025, TBA Not Confirmed.

COSMOS Pharmaceutical Corporation as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, COSMOS Pharmaceutical Corporation has paid 9.27B in taxes.

COSMOS Pharmaceutical Corporation EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

COSMOS Pharmaceutical Corporation has ¥52.30B in cash and marketable securities with ¥15.51B in debt, giving a net cash position of -¥18.24B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for COSMOS Pharmaceutical Corporation is ¥8,950.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy